Jamjoom Pharma, a leading regional pharmaceutical company headquartered in Saudi Arabia, has introduced Vivamune, an immune-boosting supplement brand developed with clinically proven Wellmune WGP.
Vivamune is a dietary supplement approved for everyday use to support immune health, particularly for adults experiencing physical and lifestyle stress. The supplement’s key active ingredient is Wellmune, the food, beverage and supplement ingredient created by Biothera to proactively support immunity.
A natural super fibre, Wellmune is a proprietary yeast beta 1,3/1,6 glucan backed by 10 clinical studies that consistently demonstrate its ability to strengthen innate immune function and improve overall health. Three of these published studies specifically demonstrate Wellmune’s ability to help keep adults healthy during times of stress.
'Consumers around the world are looking for products that can bring more health control to their lives,' said Richard G. Mueller, Biothera Chief Executive Officer. 'We are happy to be a part of Jamjoom Pharma’s Vivamune because of their dedication to creating supplements that focus on supporting the immune system as a means to improve overall health.'
'Vivamune was launched simultaneously in Riyadh, Jeddah, and Damman, attracting the participation of more than 900 doctors and health professionals,' said Dr Horia Vilcu, Senior Director, Consumer Healthcare Division of Jamjoom Pharma. 'We believe Vivamune, containing the unique Wellmune ingredient, can benefit our customers by supporting their immune systems and overall health in everyday life occasions, but also in special conditions like annual pilgrimages.'
The first product of its kind to be produced and distributed in Saudi Arabia, Vivamune is sold in capsules containing 250mg of Wellmune, and can be found in more than 1,000 stores across the country. Jamjoom Pharma has operations in more than 25 countries in the region, and Vivamune will be progressively launched in these countries.
